Nelson Sonja
Insider CIK 1674905 · NK Chief Financial Officer · MOTS Director · AMAM Chief Financial Officer · AMAM Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 55,571 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 60,714 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 121,427 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 367,799 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 50,000 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 107,143 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer | 2024-03-07 | 2024-03-07 | 22,936 | — | $0 | 0 | SEC↗ |
| MOTS Motus GI Holdings, Inc. | A Award deriv | 2024-03-05 | 2024-03-13 | 23,205 | — | $0 | 23,205 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | A Award | 2023-12-11 | 2023-12-11 | 50,000 | — | $0 | 545,776 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | S Sale | 2023-10-27 | 2023-10-31 | 12,778 | $9.82 | $125.5K | 130,079 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-07-05 | 2023-07-07 | 389,000 | — | $0 | 389,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award | 2023-04-26 | 2023-04-28 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 850,000 | — | $0 | 850,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | D To issuer deriv | 2023-01-27 | 2023-01-31 | 425,000 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 425,000 | — | $0 | 425,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | D To issuer deriv | 2023-01-27 | 2023-01-31 | 850,000 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 2,574,596 | — | $0 | 2,574,596 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | D To issuer deriv | 2023-01-27 | 2023-01-31 | 2,574,596 | — | $0 | 0 | SEC↗ |
| MOTS Motus GI Holdings, Inc. | A Award deriv | 2022-02-10 | 2022-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MOTS Motus GI Holdings, Inc. | A Award | 2022-01-05 | 2022-01-07 | 82,500 | — | $0 | 100,709 | SEC↗ |
| MOTS Motus GI Holdings, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MOTS Motus GI Holdings, Inc. | A Award | 2021-06-22 | 2021-06-23 | 18,209 | — | $0 | 18,209 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2021-01-12 | 2021-01-13 | 11,364 | — | $0 | 165,907 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2021-01-12 | 2021-01-13 | 11,364 | $3.07 | $34.9K | 31,774 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2021-01-12 | 2021-01-13 | 16,364 | $15.00 | $245.5K | 15,410 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2021-01-04 | 2021-01-06 | 22,729 | — | $0 | 177,271 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2021-01-04 | 2021-01-06 | 22,729 | $3.07 | $69.8K | 59,681 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2021-01-04 | 2021-01-06 | 39,271 | $13.62 | $534.9K | 20,410 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-08-02 | 2020-08-04 | 10,000 | — | $0 | 20,000 | SEC↗ |
| NK NantKwest, Inc. | F Tax w/h | 2020-08-02 | 2020-08-04 | 3,458 | $11.18 | $38.7K | 36,952 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-08-02 | 2020-08-04 | 10,000 | — | $0 | 40,410 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-03-23 | 2020-03-24 | 15,000 | — | $0 | 0 | SEC↗ |
| NK NantKwest, Inc. | F Tax w/h | 2020-03-23 | 2020-03-24 | 6,132 | $2.82 | $17.3K | 30,410 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-03-23 | 2020-03-24 | 15,000 | — | $0 | 36,542 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2019-08-02 | 2019-08-05 | 10,000 | — | $0 | 30,000 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2019-08-02 | 2019-08-05 | 10,000 | — | $0 | 25,000 | SEC↗ |
| NK NantKwest, Inc. | F Tax w/h | 2019-08-02 | 2019-08-05 | 3,458 | $1.27 | $4.4K | 21,542 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2018-08-27 | 2018-08-29 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2018-08-02 | 2018-08-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2018-03-23 | 2018-03-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2018-03-23 | 2018-03-26 | 15,000 | — | $0 | 15,000 | SEC↗ |